🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection

RecruitingPhase 3Ages 18 Years - anyMaleCHU de Quebec-Universite Laval
NCT05941806 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study will be a phase III double-blind randomized clinical trial. Participants will be recruited from the Department of General Surgery of the CHU de Québec - Saint-François-d'Assise and Hôtel-Dieu de Québec. The primary outcomes are the incidence of postoperative urinary retention in men undergoing rectal resection and the efficacy of prophylactic tamsulosin to prevent this type of complication.The secondary outcomes are the length of stay between experimental and placebo groups, the number of urinary catheterizations, the number of urine catheter reinsertions and total duration of urinary catheter being in-situ.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male patients * 18 years and older * Scheduled for rectal resection during the study period. Exclusion Criteria: * Patients undergoing revisional surgery * Patients taking alpha-blocker medication, * Patients who have an indwelling urinary catheter, * Patients who have undergone urinary tract surgery, * Patients who will have an intraoperative trauma of the urinary tract, * Patients who will keep their urinary catheter for more than 24 hours after surgery, * Patients who have an intolerance to alpha-blocking drugs or who take one of the following drugs (potential interaction): anti-retroviral, antifungal, clarithromycin, erythromycin, paroxetine, terbinafine, cimetidine, coumadin or phosphodiesterase inhibitors. * Patients who will have an epidural anesthesia
💊

What it tests

  • pr Sandoz Tamsulosin
  • Glucose
📍

Where

1 site
Hôpital Saint-François d'Assise
Québec, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy